The Medical Letter on Drugs and Therapeutics
Alternatives to Fluoroquinolones
June 6, 2016 (Issue: 1496)The FDA has announced that it is requiring changes in the labeling of systemic fluoroquinolones to warn that the risk of serious adverse effects, including tendinitis, peripheral neuropathy and CNS effects, generally outweighs their benefit for...more
- FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Available at: www.fda.gov. Accessed May 26, 2016.
- AM Harris et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med 2016; 164:425.
- AW Chow et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54:e72.
- RM Rosenfeld et al. Clinical practice guideline (update): adult sinusitis executive summary. Otolaryngol Head Neck Surg 2015; 152:598.
- Drugs for bacterial infections. Treat Guidel Med Lett 2013; 11:65.
- K Gupta et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52:e103.
- Drugs for urinary tract infections. Med Let Drugs Ther 2012; 54:57.
- TM Hooton. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012; 366:1028.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.